Greenwich Wealth Management LLC Sells 297 Shares of Centene Co. (NYSE:CNC)

Greenwich Wealth Management LLC lowered its position in Centene Co. (NYSE:CNC) by 0.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 37,458 shares of the company’s stock after selling 297 shares during the period. Greenwich Wealth Management LLC’s holdings in Centene were worth $2,269,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of CNC. Assetmark Inc. grew its holdings in Centene by 193.1% during the third quarter. Assetmark Inc. now owns 3,640 shares of the company’s stock valued at $274,000 after purchasing an additional 2,398 shares during the period. Sigma Planning Corp bought a new stake in Centene during the third quarter valued at about $211,000. GSA Capital Partners LLP grew its holdings in Centene by 95.2% during the third quarter. GSA Capital Partners LLP now owns 12,391 shares of the company’s stock valued at $933,000 after purchasing an additional 6,043 shares during the period. Prime Capital Investment Advisors LLC bought a new stake in Centene during the third quarter valued at about $210,000. Finally, Aptus Capital Advisors LLC grew its holdings in Centene by 6.2% during the third quarter. Aptus Capital Advisors LLC now owns 3,722 shares of the company’s stock valued at $280,000 after purchasing an additional 217 shares during the period. Institutional investors own 93.63% of the company’s stock.

Insider Activity

In other news, Director Thomas Greco acquired 17,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 18th. The shares were bought at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the completion of the purchase, the director now directly owns 19,309 shares in the company, valued at $1,153,712.75. This trade represents a 736.25 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director H James Dallas acquired 1,693 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was purchased at an average cost of $59.01 per share, for a total transaction of $99,903.93. Following the purchase, the director now owns 1,693 shares of the company’s stock, valued at $99,903.93. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.29% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on CNC shares. Oppenheimer cut their price target on Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, December 13th. JPMorgan Chase & Co. restated an “overweight” rating and issued a $75.00 price objective (down from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Stephens lowered their price objective on Centene from $75.00 to $73.00 and set an “equal weight” rating on the stock in a research report on Friday, December 13th. Argus downgraded Centene from a “buy” rating to a “hold” rating in a research report on Thursday, February 6th. Finally, Robert W. Baird boosted their target price on Centene from $66.00 to $71.00 in a research report on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, Centene has a consensus rating of “Moderate Buy” and a consensus target price of $79.92.

Centene Trading Up 0.5 %

Shares of CNC stock opened at $58.27 on Friday. Centene Co. has a 1 year low of $55.03 and a 1 year high of $80.59. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The stock’s 50 day simple moving average is $60.60 and its two-hundred day simple moving average is $63.83. The company has a market cap of $28.90 billion, a PE ratio of 9.34, a price-to-earnings-growth ratio of 0.80 and a beta of 0.40.

Centene (NYSE:CNC) last released its earnings results on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.31. The firm had revenue of $40.81 billion for the quarter, compared to analysts’ expectations of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.45 earnings per share. Research analysts predict that Centene Co. will post 6.86 earnings per share for the current year.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.